Published in Clin Pharmacol Ther on December 01, 1979
Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers. Br J Clin Pharmacol (1992) 0.81
Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter. Br J Clin Pharmacol (1994) 0.77
Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects. Br J Clin Pharmacol (1991) 0.75
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation (1983) 2.74
Protein interactions regulating vesicle transport between the endoplasmic reticulum and Golgi apparatus in mammalian cells. Cell (1997) 2.26
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol (1983) 1.76
The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab (1972) 1.75
Localization, dynamics, and protein interactions reveal distinct roles for ER and Golgi SNAREs. J Cell Biol (1998) 1.74
Relationship between electrocardiogram and electrolytes. Am Heart J (1967) 1.53
Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) (1968) 1.48
Relationship between respiratory muscle function and age, sex, and other factors. J Appl Physiol (1985) (1989) 1.38
Negative U wave: a highly specific but poorly understood sign of heart disease. Am J Cardiol (1982) 1.38
Cycle length effect on restitution of action potential duration in dog cardiac fibers. Am J Physiol (1983) 1.37
Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Ann Neurol (1977) 1.36
Fulminant beriberi heart disease with lactic acidosis: presentation of a case with evaluation of left ventricular function and review of pathophysiologic mechanisms. Circulation (1978) 1.30
Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr (1977) 1.28
Ectopic beats and atrioventricular conduction disturbances. In patients with hypopotassemia. Arch Intern Med (1967) 1.27
Electrophysiologic effects of phenothiazines on canine cardiac fibers. J Pharmacol Exp Ther (1973) 1.25
Effects of low and high concentrations of potassium on the simultaneously recorded Purkinje and ventricular action potentials of the perfused pig moderator band. Circ Res (1968) 1.22
The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses. Clin Pharmacol Ther (1982) 1.21
Ventricular fibrillation. Am J Cardiol (1971) 1.20
Pre-excitation as a cause of appearance and increased intensity of systolic murmurs. Circulation (1966) 1.17
Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol (1979) 1.10
T-wave abnormalities during hyperventilation and isoproterenol infusion. Am Heart J (1971) 1.09
A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochem J (1997) 1.08
Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization. Eur Heart J (1985) 1.08
Dispersion of ventricular repolarization and arrhythmia: study of two consecutive ventricular premature complexes. Circulation (1985) 1.08
Long QT: good, bad or indifferent? J Am Coll Cardiol (1984) 1.06
Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J (1967) 1.06
Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology (1984) 1.05
Clinical pharmacokinetics of verapamil. Clin Pharmacokinet (1984) 1.05
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol (1981) 1.04
Effects of K+ and K+-induced polarization on (dV/dt)max, threshold potential, and membrane input resistance in guinea pig and cat ventricular myocardium. Circ Res (1979) 1.04
The quest for optimal electrocardiography. Tast Force I: standardization of terminology and interpretation. Am J Cardiol (1978) 1.02
Role of electrolytes in etiology and management of cardiac arrhythmias. Prog Cardiovasc Dis (1966) 1.02
Ventricular fibrillation. J Am Coll Cardiol (1985) 1.02
Long-term prevention of paroxysmal arrhythmias with propranolol therapy. Am J Med Sci (1967) 1.01
Electrocardiogram in pericarditis. Am J Cardiol (1970) 1.00
Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol (1986) 1.00
Primary T wave abnormalities caused by uniform and regional shortening of ventricular monophasic action potential in dog. Circulation (1975) 0.99
Failure of single-session dietary counseling to reduce salt intake in hypertensive patients. South Med J (1977) 0.99
Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses. Circulation (1979) 0.99
Monophasic action potentials in man. Circulation (1968) 0.99
Antegrade and retrograde conduction characteristics in three patterns of paroxysmal atrioventricular junctional reentrant tachycardia. Am Heart J (1978) 0.99
Cardiac function in patients treated with phenothiazines. Comparison with quinidine. J Clin Pharmacol (1975) 0.98
Alternans of action potential duration after abrupt shortening of cycle length: differences between dog Purkinje and ventricular muscle fibers. Circ Res (1988) 0.98
Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res (1983) 0.98
Electrocardiographic diagnosis of chamber enlargement. J Am Coll Cardiol (1986) 0.97
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol (1991) 0.96
Action potential duration alternans in dog Purkinje and ventricular muscle fibers. Further evidence in support of two different mechanisms. Circulation (1989) 0.96
Effect of adrenergic receptor blockade on the responses to isometric handgrip: studies in normal and hypertensive subjects. J Cardiovasc Pharmacol (1980) 0.96
Exercise testing for detection of myocardial ischemia in patients with abnormal electrocardiograms at rest. Am J Cardiol (1978) 0.95
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther (2002) 0.95
The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog. Pharmacology (1983) 0.95
Ventricular septal motion and left ventriclular dimensions during abnormal ventricular activation. Am J Cardiol (1977) 0.94
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation (1982) 0.94
Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes. Arch Intern Med (1992) 0.93
Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers. Eur J Pharmacol (1985) 0.93
Sequence of repolarization on the ventricular surface in the dog. Am Heart J (1975) 0.92
Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection. Clin Chem (1983) 0.92
The QT interval and cardiac arrhythmias. Annu Rev Med (1987) 0.92
Kinetics and dynamics of nifedipine after oral and sublingual doses. Am J Med (1986) 0.92
Relation of vulnerability to ECG and action potential characteristics of premature beats. Am J Physiol (1967) 0.92
Electrocardiogram in endocrine and metabolic disorders. Cardiovasc Clin (1977) 0.91
Clinical pharmacology of slow channel blocking agents. Prog Cardiovasc Dis (1982) 0.89
Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. Ann Intern Med (1980) 0.89
Clinical pharmacokinetics of calcium channel antagonists. J Cardiovasc Pharmacol (1982) 0.89
Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations. Circulation (1978) 0.89
Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers. J Cardiovasc Pharmacol (1985) 0.88
Automatic activity in depolarized guinea pig ventricular myocardium. Characteristics and mechanisms. Circ Res (1976) 0.88
Malignant hypertension: effect of therapy on renin and aldosterone. Circ Res (1971) 0.88
Effect of nifedipine on gastric emptying in normal subjects. Dig Dis Sci (1985) 0.87
Plasma renin activity in chronic plumbism. Effect of treatment. Arch Intern Med (1971) 0.87
Fluorometric assay of verapamil in biological fluids and tissues. J Pharm Sci (1976) 0.87
Effect of tetraethylammonium chloride on action potential in cardiac Purkinje fibers. Am J Physiol (1981) 0.87
Time dependent changes in the functional properties of the atrioventricular conduction system in man. Circulation (1975) 0.86
Intracardiac extrastimulation studies: How to? Where? By whom? Circulation (1982) 0.86
Efficacy of verapamil in exercise-induced ventricular tachycardia. Am J Cardiol (1985) 0.86
Concealed interpolated A-V junctional extrasystoles and A-V junctional parasystole. Am J Cardiol (1971) 0.85
Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education. Curr Drug Saf (2013) 0.85
Cycle length-dependent action potential duration in canine cardiac Purkinje fibers. Am J Physiol (1984) 0.85
Paroxysmal ventricular tachycardia in Wolff-Parkinson-White syndrome: case report and review of the literature. J Electrocardiol (1982) 0.84
Intravenous propranolol administration: a method for rapidly achieving and sustaining desired plasma levels. Clin Pharmacol Ther (1976) 0.84
Role of the phonocardiogram in evaluation of the severity of mitral stenosis and detection of associated valvular lesions. Circulation (1966) 0.84
Bradycardia-dependent long QT syndrome, sudden death and late potentials. J Am Coll Cardiol (1992) 0.84
Familial congenital sinus rhythm anomalies: clinical and pathological correlations. Pacing Clin Electrophysiol (1992) 0.84
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae infections in Kaohsiung from 1996 through 1999. J Microbiol Immunol Infect (2001) 0.83
Tricuspid regurgitation following inferior myocardial infarction. Arch Intern Med (1976) 0.83